Made with ❤️ by True Sparrow

Bringing you the latest funding data

Trademylux Limited

Last funding round

Raised
$380,000
Round
Unknown

Funding News (1)

Feb 19 2024FinSMEs

Startup details

Trademylux Limited

Trademylux Limited

Trademylux Limited, operating as sellmyartworks.com, is a Scottish art tech startup that provides an online platform for the sales of pre-owned art pieces through traditional auction houses or other routes. It offers a secure way of acquiring and disposing artwork, creating liquidity and promoting further art transactional activity.
www.sellmyartworks.com
Edinburgh, Scotland, United Kingdom
Established in 2019
2-10 People
Consumer, Content

Founders

Bob Corsie

Chief Executive Officer

Ex: Covell Limited, Watson Gallery

Edinburgh, Scotland, United Kingdom

Investment details

Raised
$380,000
Round
Unknown
Investors
Scottish Enterprise
TRICAPITAL

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

May2024
1

Today

Bicycle raised $555M from Forbion and 6 others
UK-based Bicycle Therapeutics develops precision-guided therapeutics using 'bicycle' molecules for cancer and disease treatment.
Bicycle

Founders

Sir Gregory Winter

In News

Tech.eu
2

1 day ago

Viable raised a $3M Seed led by Martin Brailsford
London-based Viable is an Intelligent Finance platform for online and multi-channel sellers.
Viable

Founders

Henry Young,

Franklyn Martin,

Steven Haynes

In News

Silicon Canals
Tech Funding News
3

1 day ago

GreyWolf Therapeutics raised a $49.6M Series B led by ICG’s Life Sciences team
Oxfordshire-based Grey Wolf Therapeutics develops antigen modulation therapies for oncology and autoimmunity.
GreyWolf Therapeutics

Founders

Peter Joyce

In News

EU-Startups
4

2 days ago

Praktika raised a $32.5M Series A led by Blue Wire Capital
London-based Praktika delivers AI-powered language learning with personalized avatars.

Founders

Carles Reina,

Adam Turaev

In News

FinSMEs
Tech Funding News
5

3 days ago

Pheon Therapeutics raised a $120M Series B led by Research Corporation Technologies
London-based Pheon Therapeutics is an ADC specialist developing next-generation ADCs for hard-to-treat cancers.
Pheon Therapeutics

Founders

Cyrus Mozayeni

In News

FinSMEs
The pharma letter
Informazione
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.